No image available
/ 5 December 2006
Trials of a drug that was expected to save millions of people from heart attacks and stroke, ushering in a new era of protective heart medicines, have been abruptly halted after it became clear that it increased the risk of patients dying. Pfizer, the world’s biggest drug manufacturer, announced it was stopping an $800-million trial of the pill, known as torcetrapib.
Pfizer has announced that a review has concluded that Viagra doesn’t increase patients’ risk of blindness but that it is still working with federal regulators to update the drug’s label to reflect rare reports of vision loss. This follows 38 reports of blindness among Viagra users.
No image available
/ 11 February 2005
The flood of junk e-mails peddling ”Viagra” could become a thing of the past after the drug maker Pfizer joined forces with Microsoft on Thursday to file 17 lawsuits aimed at cracking down on spammers. The suits are targeted at operations selling cheaper ”generic” versions of the impotence drug and other Pfizer products.
No image available
/ 27 January 2003
An accord on the controversial issue of access to life-saving cheap medicines at the World Trade Organisation is ”fairly close”, the chief executive of US drug company Pfizer, Henry McKinnell, said on Monday.
HUNDREDS of people protested angrily outside a court here Monday after the judge hearing a suit against US drugs company Pfizer failed to turn up and case had to be adjourned. A high court in Kano, northern Nigeria, in March gave leave to three Nigerian families to sue Pfizer in a class action over tests […]
ANTONY BARNETT and STEFAANS BRMMER, Johannesburg | Friday FOR thousands of years, members of Southern Africa’s Kung tribe have eaten the Hoodia cactus to stave off hunger and thirst on long hunting trips. The Kung people – a subdivision of the San – used to cut off a stem of the cactus about the size […]
Vincent Mayanja, Kampala | Tuesday SCIENTISTS from the United States and Uganda have unveiled plans for Africa’s first major Aids facility to train medical personnel and give patients high standards of care. The $11-million facility is being funded by pharmaceutical giant Pfizer, and will be based in Kampala as part of the city’s main Mulago […]
THE trial of the US drugs company Pfizer over a 1996 drug test that killed 11 children in northern Nigeria has stalled due to the absence of a victim’s lawyer. Three Nigerian families have filed suit against Pfizer over tests it carried out of a new drug, Trovan or Trovafloxacin, during a meningitis epidemic in […]
No image available
/ 17 January 2001
MORE than 200_000 doses of antibiotics, donated by US pharmaceutical company Pfizer for use in fighting trachoma – an eye disease affecting 142 million people worldwide – are to be sent soon to Mali. The announcement was made by the International Trachoma Initiative jointly with the Malian Minister of Health. One third of all children […]
No image available
/ 30 November 2000
THE US pharmaceutical giant Pfizer is to unveil plans to provide the South African government with a two-year supply of its Aids medication Diflucan at no cost, a company spokesman said. Diflucan – known generically as fluconazole – is an anti-fungal drug used to treat cryptococcal meningitis, a potentially fatal brain affliction, as well as […]